About Teva Pharmaceuticals
Teva Pharmaceuticals is a company based in Petah Tikva (Israel) founded in 1901.. Teva Pharmaceuticals has raised $500 million across 3 funding rounds from investors including European Union. The company has 51,792 employees as of December 31, 2017. Teva Pharmaceuticals has completed 17 acquisitions, including Actavis, Actavis and Anda.
- Headquarter Petah Tikva, Israel
- Employees 51792 as on 31 Dec, 2017
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Teva Pharmaceutical Industries Limited
-
Annual Revenue
$14.69 M (USD)-41as on Mar 31, 2024
-
Net Profit
$755.03 K (USD)8as on Mar 31, 2024
-
EBITDA
$1.01 M (USD)8as on Mar 31, 2024
-
Total Equity Funding
$500 M (USD)
in 3 rounds
-
Latest Funding Round
$2.3 B (USD), Debt – Conventional
Apr 10, 2019
- Investors
-
Employee Count
51792
as on Dec 31, 2017
-
Investments & Acquisitions
Actavis
& 16 more
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Teva Pharmaceuticals
Teva Pharmaceuticals is a publicly listed company on the TASE with ticker symbol TEVA in Israel, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Unlock access to complete
Unlock access to complete
Software Development Team
297 people
Leadership Team
186 people
Sales and Marketing
89 people
Senior Team
53 people
Human Resources and Administration
48 people
Operations Team
47 people
Product Management Team
41 people
Finance and Accounting
35 people
Unlock access to complete
Funding Insights of Teva Pharmaceuticals
Teva Pharmaceuticals has successfully raised a total of $500M across 3 strategic funding rounds. The most recent funding activity was a Debt – Conventional round of $2.3 billion completed in April 2019. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 3
- Last Round Debt – Conventional — $2.3B
-
First Round
First Round
(02 Dec 2009)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr, 2019 | Amount | Debt – Conventional - Teva Pharmaceuticals | Valuation |
investors |
|
| Mar, 2018 | Amount | Grant - Teva Pharmaceuticals | Valuation |
investors |
|
| Dec, 2009 | Amount | Private Equity Round - Teva Pharmaceuticals | Valuation |
investors |
|
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Teva Pharmaceuticals
Teva Pharmaceuticals has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Teva Pharmaceuticals
Teva Pharmaceuticals has strategically engaged in corporate development activities, having acquired 17 companies. Notable acquisitions include Actavis, Actavis and Anda. These strategic investments and acquisitions demonstrate the company's commitment to growth through portfolio expansion, market consolidation, technology integration, and strategic partnerships that enhance competitive positioning and drive long-term value creation.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Mobile app and sensor to manage asthma through gamification
|
2012 | ||||
|
Biologic treatments for chronic and episodic migraines are developed.
|
2012 | ||||
|
Generic pharmaceutical products are manufactured for musculoskeletal treatments.
|
2011 |
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
OVO is recognized as a smart digital payment application.
|
2017 | ||||
|
Bionic investment advisor platform
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 |
Financial Statements - Teva Pharmaceuticals
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Teva Pharmaceuticals Comparisons
Competitors of Teva Pharmaceuticals
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Teva Pharmaceuticals
Frequently Asked Questions about Teva Pharmaceuticals
When was Teva Pharmaceuticals founded?
Teva Pharmaceuticals was founded in 1901 and raised its 1st funding round 108 years after it was founded.
Where is Teva Pharmaceuticals located?
Teva Pharmaceuticals is headquartered in Petah Tikva, Israel. It is registered at Petah Tikva, Central District, Israel.
Who is the current CEO of Teva Pharmaceuticals?
Richard Francis is the current CEO of Teva Pharmaceuticals.
Is Teva Pharmaceuticals a funded company?
Teva Pharmaceuticals is a funded company, having raised a total of $500M across 3 funding rounds to date. The company's 1st funding round was a Private Equity Round of $500M, raised on Dec 02, 2009.
How many employees does Teva Pharmaceuticals have?
As of Dec 31, 2017, the latest employee count at Teva Pharmaceuticals is 51,792.
What is the annual revenue of Teva Pharmaceuticals?
Annual revenue of Teva Pharmaceuticals is $14.69M as on Mar 31, 2024.
What does Teva Pharmaceuticals do?
Teva Pharmaceuticals was founded in 1901 in Petah Tikva, Israel, where operations in the pharmaceutical sector are centered on generic drug production. Revenues of 14.94 billion were reported for 2023, alongside a net loss of 2.35 billion. Leadership is provided by CEO Richard Francis, with activities spanning global manufacturing and distribution of medications.
Is Teva Pharmaceuticals publicly traded?
Yes, Teva Pharmaceuticals is publicly traded on TASE under the ticker symbol TEVA.
How many acquisitions has Teva Pharmaceuticals made?
Who are Teva Pharmaceuticals's investors?
Teva Pharmaceuticals has 1 investor. Key investors include European Union.
What is Teva Pharmaceuticals's ticker symbol?
The ticker symbol of Teva Pharmaceuticals is TEVA on TASE.
Book a demo & talk to our team
Share a few details and we’ll reach out to schedule a session.